| Progranulin oncogenic axis in solid tumor: novel target for therapy A Morrione National Cancer Institute, 2024 | | 2024 |
| Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches C Mancarella, A Morrione, K Scotlandi International Journal of Molecular Sciences 25 (11), 5915, 2024 | | 2024 |
| Characterization of KLHL14 anti-oncogenic action in malignant mesothelioma A Canciello, RB Domínguez, B Barboni, A Giordano, A Morrione Heliyon 10 (6), 2024 | 2 | 2024 |
| Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review D Rosati, M Palmieri, G Brunelli, A Morrione, F Iannelli, E Frullanti, ... Computational and structural biotechnology journal, 2024 | 3 | 2024 |
| CSF-1R in cancer: More than a myeloid cell receptor F Cersosimo, S Lonardi, C Ulivieri, P Martini, A Morrione, W Vermi, ... Cancers 16 (2), 282, 2024 | 3 | 2024 |
| Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives A Costagliola, R Lombardi, G Liguori, A Morrione, A Giordano Cancer Genomics & Proteomics 20 (6suppl), 637-645, 2023 | 1 | 2023 |
| PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas C Mancarella, A Morrione, K Scotlandi International Journal of Molecular Sciences 24 (22), 16346, 2023 | 3 | 2023 |
| Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells E Ventura, A Belfiore, RV Iozzo, A Giordano, A Morrione American Journal of Physiology-Cell Physiology 325 (2), C391-C405, 2023 | 2 | 2023 |
| Progranulin oncogenic network in solid tumors E Ventura, G Ducci, R Benot Dominguez, V Ruggiero, A Belfiore, E Sacco, ... Cancers 15 (6), 1706, 2023 | 9 | 2023 |
| The effect of sex on disease stage and survival after radical cystectomy in non-Urothelial Variant-Histology bladder cancer RS Flammia, A Tufano, F Chierigo, C Würnschimmel, B Hoeh, G Sorce, ... Journal of Clinical Medicine 12 (5), 1776, 2023 | 3 | 2023 |
| IGF2: a role in metastasis and tumor evasion from immune surveillance? A Belfiore, RV Rapicavoli, R Le Moli, R Lappano, A Morrione, ... Biomedicines 11 (1), 229, 2023 | 19 | 2023 |
| Mitochondrial dysfunction: the hidden player in the pathogenesis of atherosclerosis? G Ciccarelli, S Conte, G Cimmino, P Maiorano, A Morrione, A Giordano International Journal of Molecular Sciences 24 (2), 1086, 2023 | 35 | 2023 |
| Hybrid E/M states: a bridge between stem cell plasticity, tumorigenicity and tissue regeneration A Canciello, A Peserico, A Cerverò-Varona, G Prencipe, M EL KHATIB, ... Stem Cell Research Italy-One Day Meeting, GIOVANI RICERCATORI A CONFRONTO, 2023 | | 2023 |
| IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 2023, 11, 229 A Belfiore, RV Rapicavoli, R Le Moli, R Lappano, A Morrione, ... | 1 | 2023 |
| Progranulin modulates RYK and EGFR activity in mesothelioma cells E Ventura, R Iozzo, A Belfiore, A Giordano, A Morrione Journal of Biological Chemistry 299 (3), 104337, 2023 | | 2023 |
| Complexity of progranulin mechanisms of action in mesothelioma E Ventura, C Xie, S Buraschi, A Belfiore, RV Iozzo, A Giordano, ... Journal of Experimental & Clinical Cancer Research 41 (1), 333, 2022 | 5 | 2022 |
| “In medio stat virtus”: Insights into hybrid E/M phenotype attitudes A Canciello, A Cerveró-Varona, A Peserico, A Mauro, V Russo, ... Frontiers in Cell and Developmental Biology 10, 1038841, 2022 | 12 | 2022 |
| Neuro–immune interactions in severe COVID-19 infection E Rossi, L Mutti, A Morrione, A Giordano Pathogens 11 (11), 1256, 2022 | 2 | 2022 |
| Prognostic significance of organ-specific metastases in patients with metastatic upper tract urothelial carcinoma A Tufano, N Cordua, V Nardone, R Ranavolo, RS Flammia, F D’Antonio, ... Journal of Clinical Medicine 11 (18), 5310, 2022 | 12 | 2022 |
| Mechanisms of action and regulation of the progranulin/EphA2 axis in mesothelioma E Ventura, S Buraschi, SJ Williams, A Belfiore, RV Iozzo, A Giordano, ... Cancer Research 82 (12_Supplement), 97-97, 2022 | | 2022 |
Antonino BelfioreProfessor of Endocrinology, University of Catania在 unict.it 的电子邮件经过验证
